Crescent Biopharma CBIO
NASDAQ CBIO
$14.48 +0.56 (+4.02%)
As of: Nov 11, 2026 · 3:01 PM EST

Crescent Biopharma (CBIO) Return on Sales [ROS] (2013 - 2026)

Updated

Crescent Biopharma (CBIO) reported Return on Sales [ROS] of -16214.63% for Q2 2026, up 18295.88 percentage points from -34510.51% a year earlier but down 13834.55 percentage points from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Return on Sales [ROS] (2013 - 2026) Analysis & Trends

For FY2025, Crescent Biopharma posted Return on Sales [ROS] of -1407.52%, up 2873.50 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of -900.69 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -4281.03% in FY2024 (+388471.90 pp), -392752.93% in FY2023 (-329548.50 pp), -63204.43% in FY2022 (-57733.74 pp) and -5470.69% in FY2021 (-4963.85 pp).
  • Five-year quarterly Return on Sales [ROS] spans a low of -207385.91% in Q1 2022 and a high of -1330.78% in Q2 2023.
  • Year over year, Return on Sales [ROS] gained in two of the last six quarters, with an average year-over-year change of -3394.07 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q2 2022 (a gain of 10126197.20 percentage points); the low point was Q1 2022 (a drop of 206032.93 percentage points).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Crescent Biopharma 386.36 Mn -320.93 Mn - -4,937.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,937.57%
Mar 31, 2026 -2,380.08%
Dec 31, 2025 -8,355.43%
Sep 30, 2025 -2,025.43%
Jun 30, 2025 -34,510.51%
Mar 31, 2025 -11,863.37%
Dec 31, 2024 -6,046.95%
Sep 30, 2024 -6,088.12%
Jun 30, 2024 -3,948.98%
Mar 31, 2024 -2,937.69%
Dec 31, 2023 -1,872.50%
Sep 30, 2023 -1,606.19%
Jun 30, 2023 -1,330.78%
Mar 31, 2023 -1,880.97%
Dec 31, 2022 -57,760.32%
Sep 30, 2022 -54,372.95%
Jun 30, 2022 -17,804.21%
Mar 31, 2022 -207,385.91%
Dec 31, 2021 -98,870.20%
Sep 30, 2021 -20,028.82%
API Access

Crescent Biopharma Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CBIO&period=max&api_key=YOUR_API_KEY